Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.

[1]  M. Foss,et al.  Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. , 2009, JAMA.

[2]  A. Giordano,et al.  From the laboratory bench to the patient's bedside: An update on clinical trials with mesenchymal stem cells , 2007, Journal of cellular physiology.

[3]  Darwin J. Prockop,et al.  Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice , 2006, Proceedings of the National Academy of Sciences.

[4]  J. V. van Laar,et al.  Adult stem cells in the treatment of autoimmune diseases. , 2006, Rheumatology.

[5]  I. Rasmusson.  Immune modulation by mesenchymal stem cells. , 2006, Experimental cell research.

[6]  Hanns-Ulrich Marschall,et al.  Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease , 2006, Transplantation.

[7]  Nils Welsh,et al.  Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. , 2005, Diabetes.

[8]  I. Concha,et al.  Novel expression of liver FBPase in Langerhans islets of human and rat pancreas , 2005, Journal of cellular physiology.

[9]  M. Richard,et al.  Mesenchymal stem cells induce apoptosis of activated T cells , 2005, Leukemia.

[10]  H. Nakagawa,et al.  Human mesenchymal stem cells successfully improve skin‐substitute wound healing , 2005, The British journal of dermatology.

[11]  R. Poulsom,et al.  Proliferation of bone marrow-derived cells contributes to regeneration after folic acid-induced acute tubular injury. , 2005, Journal of the American Society of Nephrology : JASN.

[12]  Young Soo Kim,et al.  In vitro trans-differentiation of rat mesenchymal cells into insulin-producing cells by rat pancreatic extract. , 2005, Biochemical and biophysical research communications.

[13]  M. Rojas,et al.  Bone marrow-derived mesenchymal stem cells in repair of the injured lung. , 2005, American journal of respiratory cell and molecular biology.

[14]  O. Ringdén,et al.  Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[15]  O. Pivetta,et al.  Early Manifestations in Multiple-low-dose Streptozotocin-induced Diabetes in Mice , 2005, Pancreas.

[16]  W. Vaughn,et al.  Mesenchymal Stem Cells Differentiate into an Endothelial Phenotype, Enhance Vascular Density, and Improve Heart Function in a Canine Chronic Ischemia Model , 2005, Circulation.

[17]  G. Camussi,et al.  Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. , 2004, International journal of molecular medicine.

[18]  Li-Bo Chen,et al.  Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells. , 2004, World journal of gastroenterology.

[19]  H. Lerche,et al.  Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells , 2004, Journal of Cell Science.

[20]  Fei Ye,et al.  Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. , 2004, The American journal of cardiology.

[21]  B. Burkhardt,et al.  In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. , 2004, Diabetes.

[22]  Roland Meisel,et al.  Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. , 2004, Blood.

[23]  Lan Wang,et al.  No evidence for significant transdifferentiation of bone marrow into pancreatic beta-cells in vivo. , 2004, Diabetes.

[24]  O. Ringdén,et al.  HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. , 2003, Experimental hematology.

[25]  R. Kawamori,et al.  Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic beta cells , 2003, Diabetologia.

[26]  L. Cantley,et al.  Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. , 2003, The Journal of clinical investigation.

[27]  Li Li,et al.  Bone marrow–derived stem cells initiate pancreatic regeneration , 2003, Nature Biotechnology.

[28]  M. Hussain,et al.  In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion , 2003 .

[29]  L. Fouillard,et al.  Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma , 2003, Leukemia.

[30]  M. Brownlee.  Insight Review Articles , 2022 .

[31]  Christophe Benoist,et al.  β-Cell death during progression to diabetes , 2001, Nature.

[32]  M. Okabe,et al.  Bone marrow is a reservoir of repopulating mesangial cells during glomerular remodeling. , 2001, Journal of the American Society of Nephrology : JASN.

[33]  R. Poulsom,et al.  Bone marrow contributes to renal parenchymal turnover and regeneration , 2001, The Journal of pathology.

[34]  S. Bruder,et al.  Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. , 2001, Trends in molecular medicine.

[35]  F. Karlsson,et al.  Islet loss and alpha cell expansion in type 1 diabetes induced by multiple low-dose streptozotocin administration in mice. , 2000, The Journal of endocrinology.

[36]  R. Wolfe,et al.  Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. , 1999, The New England journal of medicine.

[37]  P. Conget,et al.  Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells , 1999, Journal of cellular physiology.

[38]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[39]  Darwin J. Prockop,et al.  Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta , 1999, Nature Medicine.

[40]  D. Allan,et al.  BETA‐CELL APOPTOSIS IS RESPONSIBLE FOR THE DEVELOPMENT OF IDDM IN THE MULTIPLE LOW‐DOSE STREPTOZOTOCIN MODEL , 1996, The Journal of pathology.

[41]  A I Caplan,et al.  The mesengenic process. , 1994, Clinics in plastic surgery.

[42]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[43]  G. Eknoyan,et al.  Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[44]  Eld,et al.  COMPARISON OF MORTALITY IN ALL PATIENTS ON DIALYSIS , PATIENTS ON DIALYSIS AWAITING TRANSPLANTATION , AND RECIPIENTS OF A FIRST CADAVERIC TRANSPLANT , 2000 .